Loading clinical trials...
Loading clinical trials...
Single System Double Blinded Trial to Evaluate the Effect of Pre-operative Treatment With DigiFab to Prevent Post-operative Acute Kidney Injury (AKI) in Patients at High Risk for AKI Undergoing Cardiac Bypass Graft Surgery
Conditions
Interventions
Digoxin Antibodies Fab Fragments
Placebo
+2 more
Locations
2
United States
University of Maryland
Baltimore, Maryland, United States
St Josephs Medical Center
Baltimore, Maryland, United States
Start Date
July 22, 2019
Primary Completion Date
April 30, 2024
Completion Date
April 30, 2024
Last Updated
July 2, 2025
NCT05806645
NCT07472426
NCT07447791
NCT07106151
NCT07418242
NCT05879432
Lead Sponsor
University of Maryland, Baltimore
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions